Cargando…

Prediction of a high-risk group based on postoperative nadir CA-125 levels in patients with advanced epithelial ovarian cancer

OBJECTIVE: We aimed to determine the ideal cut-off of nadir serum CA-125 level for prediction of progression free survival. METHODS: Among 267 patients who achieved complete remission after chemotherapy, the correlation between nadir CA-125 and progression free survival were compared among the subgr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Sokbom, Kim, Tae-Joong, Seo, Sang-Soo, Kim, Byoung-Gie, Bae, Duk-Soo, Park, Sang-Yoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Gynecologic Oncology and Colposcopy 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254846/ https://www.ncbi.nlm.nih.gov/pubmed/22247804 http://dx.doi.org/10.3802/jgo.2011.22.4.269

Ejemplares similares

Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2016)

Significance of serum CA125 level in surgically resected cervical adenocarcinoma with adverse features
por: Kim, Nalee, et al.
Publicado: (2021)

Survival Effects of Cytoreductive Surgery for Refractory Patients after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer
por: Shin, Wonkyo, et al.
Publicado: (2020)

Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer
por: Xu, Xia, et al.
Publicado: (2013)

Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer
por: Piatek, Szymon, et al.
Publicado: (2021)

The Effect of CA125 Nadir Level on Survival of Advanced-Stage Epithelial Ovarian Carcinoma after Interval Debulking Surgery
por: Zeng, Jing, et al.
Publicado: (2017)

Single-port access laparoscopic staging operation for a borderline ovarian tumor
por: Yoon, Aera, et al.
Publicado: (2011)

Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2016)

Molecular Signature for Lymphatic Invasion Associated with Survival of Epithelial Ovarian Cancer
por: Paik, E Sun, et al.
Publicado: (2018)

Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2018)

Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff?
por: Kim, Jihye, et al.
Publicado: (2018)

Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer
por: Park, Jin-Young, et al.
Publicado: (2016)

Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer
por: Kang, Heeseok, et al.
Publicado: (2009)

Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods
por: Paik, E Sun, et al.
Publicado: (2019)

Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification
por: Paik, E Sun, et al.
Publicado: (2015)

Prevalence and oncologic outcomes of BRCA1/2 mutation and variant of unknown significance in epithelial ovarian carcinoma patients in Korea
por: Seo, Jun Hyeong, et al.
Publicado: (2019)

Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012
por: Kim, Se Ik, et al.
Publicado: (2016)

Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis
por: Paik, E Sun, et al.
Publicado: (2018)

The anti-cancer effects of itraconazole in epithelial ovarian cancer
por: Choi, Chel Hun, et al.
Publicado: (2017)

Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
por: Jeong, Soo Young, et al.
Publicado: (2019)

The Knowledge and Attitude of Patients Diagnosed with Epithelial Ovarian Cancer towards Genetic Testing
por: Shin, Wonkyo, et al.
Publicado: (2021)

Histologic distribution of borderline ovarian tumors worldwide: a systematic review
por: Song, Taejong, et al.
Publicado: (2013)

Ovarian metastasis from pulmonary adenocarcinoma
por: Jung, Young-Eun, et al.
Publicado: (2013)

Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma
por: Lee, Yoo-Young, et al.
Publicado: (2015)

Perioperative administration of propranolol to women undergoing ovarian cancer surgery: A pilot study
por: Jang, Hye-In, et al.
Publicado: (2017)

Retrospective study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer
por: Shin, Wonkyo, et al.
Publicado: (2018)

The effects of selenium on tumor growth in epithelial ovarian carcinoma
por: Park, Jin Sun, et al.
Publicado: (2012)

Combination of a pulmonary recruitment maneuver and intraperitoneal bupivacaine for the reduction of postoperative shoulder pain in gynecologic laparoscopy: a randomized, controlled trial
por: Cho, Minae, et al.
Publicado: (2020)

Prostate-Specific Antigen Nadir and Time to Prostate-Specific Antigen Nadir Following Maximal Androgen Blockade Independently Predict Prognosis in Patients with Metastatic Prostate Cancer
por: Hong, Seok Young, et al.
Publicado: (2012)

Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies
por: Heo, Eun Jin, et al.
Publicado: (2017)

Feasibility of Single-Port Access (SPA) Laparoscopy for Large Ovarian Tumor Suspected to Be Borderline Ovarian Tumor
por: Kang, Jun-Hyeok, et al.
Publicado: (2020)

Nadir CA-125 serum levels during neoadjuvant chemotherapy and no residual tumor at interval debulking surgery predict prognosis in advanced stage ovarian cancer
por: Nakamura, Kazuto, et al.
Publicado: (2020)

Metastatic Skin Lesions on Lower Extremities in a Patient with Recurrent Serous Papillary Ovarian Carcinoma: A Case Report and Literature Review
por: Kim, Moon-Kyung, et al.
Publicado: (2012)

How to manage synchronous endometrial and ovarian cancer patients?
por: Shin, Wonkyo, et al.
Publicado: (2021)

Completeness of pedigree and family cancer history for ovarian cancer patients
por: Son, Yedong, et al.
Publicado: (2014)

Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer
por: Paik, E Sun, et al.
Publicado: (2017)

Synchronous gynecologic malignancy and preliminary results of Lynch syndrome
por: Kim, Min Kyu, et al.
Publicado: (2011)

Survival outcomes after extensive cytoreductive surgery and selective neoadjuvant chemotherapy according to institutional criteria in bulky stage IIIC and IV epithelial ovarian cancer
por: Lim, Myong Cheol, et al.
Publicado: (2017)

Addendum: Shin, W.; et al. The Knowledge and Attitude of Patients Diagnosed with Epithelial Ovarian Cancer towards Genetic Testing. Int. J. Environ. Res. Public Health 2021, 18, 2312
por: Shin, Wonkyo, et al.
Publicado: (2021)

Preclinical assessment of the VEGFR inhibitor axitinib as a therapeutic agent for epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5lq9prd9s5e5af92b684o9cl3d